ClinicalTrials.Veeva

Menu

UCSD Take Charge Study

University of California San Diego logo

University of California San Diego

Status

Completed

Conditions

Diabetic
Obese
Overweight
Obesity
Type 2 Diabetes

Treatments

Other: Lower carbohydrate, Higher fat diet
Other: Individualized Counseling
Other: Higher Carbohydrate, Lower Fat Diet

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The purpose of the Take Charge Study is to determine among overweight and obese men and women with type 2 diabetes whether 1) participating in a commercial weight loss program promotes great weight loss and weight loss maintenance at one year compared to usual care conditions and 2) whether there is a differential weight loss response to different dietary macronutrient composition (lower carbohydrate/higher fat diet versus a higher carbohydrate/lower fat).

Enrollment

227 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Aged 18 years or older
  • Type 2 diabetes
  • BMI 25-45 kg/m2
  • Willing to participate in any of the study diet arms (higher or lower carbohydrate diet or usual care) over a one-year period
  • Able to comply with all required study procedures and schedule
  • Must live within the San Diego or Minneapolis area

Exclusion criteria

  • Pregnant, breastfeeding or planning to become pregnant in the next year
  • Serious medical condition or psychiatric illness
  • History of having an eating disorder, food allergy or food intolerance
  • Have food restrictions or requires a special diet
  • Objects to frozen, processed or prepackaged foods
  • Inability to be moderately physically active
  • Currently enrolled in a weight loss program or another diet intervention
  • Current use of weight loss medication or supplements
  • Planned surgical procedure that can impact the conduct of the study
  • Previous surgical procedures for weight reduction
  • Does not have own transportation
  • Have plans to relocate from area within 1 year
  • HbA1C >11%, fasting triglycerides >600 mg/dL, serum creatinine >1.4 mg/dL (women) or 1.5 mg/dL (men) -- to be screened at baseline visit

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

227 participants in 3 patient groups

Higher Carbohydrate/Lower Fat Diet
Experimental group
Treatment:
Other: Higher Carbohydrate, Lower Fat Diet
Lower Carbohydrate/Higher Fat Diet
Experimental group
Treatment:
Other: Lower carbohydrate, Higher fat diet
Individualized Counseling
Active Comparator group
Treatment:
Other: Individualized Counseling

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems